Aurinia Pharmaceuticals Inc. (AUPH)

PriceLoading quote

Financial charts

Revenue

Net income

Free cash flow

Total cash / debt

CashTotal debt

Financial statements

10 annual periodsNewest to oldest
2025202420232022202120202019201820172016
Revenue$283.1M$235.1M$175.5M$134.0M$45.6M$50.1M$318,000$463,000$418,000$173,000
Research & development$32.5M$20.8M$49.6M$45.0M$51.1M$50.3M$52.9M$41.4M$33.9M$14.5M
Operating expenses$178.1M$239.8M$267.2M$154.4M$91.3M$55.7M$47.3M$25.2M
Operating income$104.9M−$4.7M−$91.7M−$111.5M−$180.7M−$104.3M−$90.9M−$55.2M−$46.9M−$25.0M
EBITDAderived$124.4M$14.8M−$80.0M−$108.8M−$178.0M−$102.9M−$89.8M−$53.9M−$45.4M−$23.5M
Net income$287.2M$5.8M−$78.0M−$108.2M−$181.0M−$102.7M−$88.4M−$53.1M−$70.8M−$23.3M
Basic EPSper diluted share$2.14$0.04-$0.54-$0.76-$1.40-$0.87-$0.95-$0.63-$0.92-$0.66
Diluted EPSper diluted share$2.07$0.04-$0.54-$0.76-$1.40-$0.87-$0.95-$0.63-$0.92-$0.66

Insider buys & sells

Jul 1, 2024Jun 30, 2026
Buys23$62.27M disclosed value
Sells (SEC code S)14$6.34M disclosed value
37 recent transactions
TransactionInsiderTypeSharesPriceValueOwned after
Jun 2, 2026Form 4TANG KEVIN +1Chief Executive OfficerBuyCommon Shares · indirect206.0K$15.28$3.15M13.04M
Jun 1, 2026Form 4TANG KEVIN +1Chief Executive OfficerBuyCommon Shares · indirect99$15.34$1.5K12.84M
Jun 1, 2026Form 4TANG KEVIN +1Chief Executive OfficerBuyCommon Shares · indirect343.5K$15.28$5.25M12.84M
May 29, 2026Form 4TANG KEVIN +1Chief Executive OfficerBuyCommon Shares · indirect262.7K$15.31$4.02M12.49M
May 29, 2026Form 4TANG KEVIN +1Chief Executive OfficerBuyCommon Shares · indirect2.3K$15.35$35.3K12.23M